Developing Consensus on Evaluations for Functional Ingredients in Infant Formula
From Human Milk Components to Clinical Evidence
A Workshop
All times in Eastern Standard Time (EST)
Monday, March 2, 2026
9:00 – 9:20 am
Introduction to the INSC and Workshop Overview
Sharon Donovan, University of Illinois Urbana-Champaign (INSC Steering Committee Co-Chair)
Paul Hanlon, Abbott Nutrition (INSC Steering Committee Co-Chair)
9:20 – 9:30 am
Perspectives Paper Overview
David Dallas, Oregon State University (INSC Steering Committee and Workshop Planning Committee Member)
Session 1 – Human Milk as a Guide for Inclusion of Components in Infant Formula
9:30 – 9:40 am
Moderator Opening Remarks
Kasper Hettinga, Wageningen University
(INSC Workshop Planning Committee Member)
9:40 – 10:45 am
Panelist Discussion
Lindsay Allen, USDA/ARS; UC Davis
Manki Ho, Novonesis
Michelle (Shelley) McGuire, University of Idaho
Ashley Patterson, Mead Johnson Nutrition
Anthony (Tony) Pavel, Keller & Heckman
~10:45 – 11:00 am
Break
11:00 – 12:30 pm
Panelist Discussion (cont.)
Lindsay Allen, USDA/ARS; UC Davis
Manki Ho, Novonesis
Michelle (Shelley) McGuire, University of Idaho
Ashley Patterson, Mead Johnson Nutrition
Anthony (Tony) Pavel, Keller & Heckman
12:30 – 12:40 pm
Moderator Closing Remarks
Kasper Hettinga, Wageningen University
12:40 – 1:50 pm
Lunch Break
Session 2 – Preclinical Models for Evaluating Ingredients
1:50 – 2:00 pm
Moderator Opening Remarks
Douglas Burrin, USDA/ARS; Baylor College of Medicine
(INSC Steering Committee and Workshop Planning Commmittee Member)
2:00 – 3:15 pm
Panelist Discussion
Sharon Donovan, University of Illinois Urbana-Champaign
Paul Hanlon, Abbott Nutrition
Dennis Keefe, Exponent; FDA (former)
Claire Kruger, Spherix Consulting Group
Caitlin Vonderohe, Baylor College of Medicine
Laxmi Yeruva, USDA/ARS; University of Arkansas for Medical Sciences
~3:15 – 3:30 pm
Break
3:30 – 4:50 pm
Panelist Discussion (cont.)
Sharon Donovan, University of Illinois Urbana-Champaign
Paul Hanlon, Abbott Nutrition
Dennis Keefe, Exponent; FDA (former)
Claire Kruger, Spherix Consulting Group
Caitlin Vonderohe, Baylor College of Medicine
Laxmi Yeruva, USDA/ARS; University of Arkansas for Medical Sciences
4:50 – 5:00 pm
Moderator Closing Remarks
Douglas Burrin, USDA/ARS; Baylor College of Medicine
5:00 pm
Adjourn Day 1
Tuesday, March 3, 2026
9:00 – 9:10 am
Summary of Sessions 1 and 2
Marie Ryan and Clay Swackhamer, Oregon State University
Session 3 – Clinical Endpoints for Evaluating Safety and Suitability of Ingredients in Infant Formula
9:10 – 9:20 am
Moderator Opening Remarks
Vanessa Castagna, SciPinion
(INSC Steering Committee and Workshop Planning Commmittee Member)
9:20 – 10:45 am
Panelist Discussion
John Colombo, University of Kansas
Susan Dallabrida, SPRIM PRO
Mona Eskander, Health Canada (former)
Leanne Redman, Pennington Biomedical Research Center; University of Sydney
Alan Ryan, Clinical Research Consulting; FDA (former)
Barbara Schneeman, UC Davis (emeritus); FDA (former)
~10:45 – 11:00 am
Break
11:00 – 12:20 pm
Panelist Discussion (cont.)
John Colombo, University of Kansas
Susan Dallabrida, SPRIM PRO
Mona Eskander, Health Canada (former)
Leanne Redman, Pennington Biomedical Research Center; University of Sydney
Alan Ryan, Clinical Research Consulting; FDA (former)
Barbara Schneeman, UC Davis (emeritus); FDA (former)
12:20 – 12:30 pm
Moderator Closing Remarks
Vanessa Castagna, SciPinion
12:30 pm
Adjourn Workshop